Drug Profile
Trichomoniasis therapeutic - Setubio
Alternative Names: PhytogynalLatest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Setubio
- Class Antiparasitics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Trichomoniasis
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Trichomoniasis in France
- 05 Jul 2016 Early research in Trichomoniasis in France (unspecified route)